100 related articles for article (PubMed ID: 6656907)
1. [The safety of Tolvon].
Hermans RB
Ned Tijdschr Geneeskd; 1983 Nov; 127(48):2203. PubMed ID: 6656907
[No Abstract] [Full Text] [Related]
2. Mianserin differentiated from tricyclic antidepressants.
Jansen FH
JAMA; 1978 Sep; 240(13):1339. PubMed ID: 682321
[No Abstract] [Full Text] [Related]
3. Two clinical syndromes and mianserin.
Tulloch AE
Lancet; 1978 May; 1(8073):1097. PubMed ID: 77391
[No Abstract] [Full Text] [Related]
4. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
Chaplin S
Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881
[No Abstract] [Full Text] [Related]
5. [Agranulocytosis during treatment with mianserin (Tolvon)].
Skallgård F
Ugeskr Laeger; 1981 Nov; 143(46):3057. PubMed ID: 7331004
[No Abstract] [Full Text] [Related]
6. Pulmonary reaction to mianserin (Tolvon).
Brooks AM
Med J Aust; 1980 Aug; 2(4):226. PubMed ID: 7432303
[No Abstract] [Full Text] [Related]
7. Tolvon and toxic epidermal necrolysis.
Boettcher B
Med J Aust; 1980 Mar; 1(6):280-1. PubMed ID: 7374593
[No Abstract] [Full Text] [Related]
8. Tolvon and toxic epidermal necrolysis.
Randell P
Med J Aust; 1979 Dec; 2(12):653. PubMed ID: 537557
[No Abstract] [Full Text] [Related]
9. Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics.
O'Donnell JL; Sharman JR; Begg EJ; Colls BM; Moller PW
Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1375-6. PubMed ID: 3933676
[TBL] [Abstract][Full Text] [Related]
10. [Immunoallergic hemolytic anemia caused by metapramine].
Coppéré B; Perrot D; Ninet J; Meyer F; Benes C; Girard-Madoux MH; Motin J; Evreux JC
Ann Med Interne (Paris); 1993; 144(1):70. PubMed ID: 8503619
[No Abstract] [Full Text] [Related]
11. Antidepressant medication.
Shaw WL
Ir Med J; 1981 Mar; 74(3):97. PubMed ID: 7203989
[No Abstract] [Full Text] [Related]
12. Possible mirtazapine-induced rhabdomyolysis.
Khandat AB; Nurnberger JI; Shekhar A
Ann Pharmacother; 2004; 38(7-8):1321. PubMed ID: 15187213
[No Abstract] [Full Text] [Related]
13. Mirtazapine and the granulocytes--so far so good.
Meyboom RH; Edwards IR; Egberts AC
N Z Med J; 1999 Mar; 112(1084):104. PubMed ID: 10210300
[No Abstract] [Full Text] [Related]
14. Non-lethal mirtazapine overdose with rhabdomyolysis.
Kuliwaba A
Aust N Z J Psychiatry; 2005 Apr; 39(4):312-3. PubMed ID: 15777372
[No Abstract] [Full Text] [Related]
15. Acute reversible dyskinesia induced by mirtazapine.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
[No Abstract] [Full Text] [Related]
16. Mirtazapene: a noradrenergic and specific serotonergic antidepressant.
Gray R
Ment Health Care; 1998 Mar; 1(7):233-4. PubMed ID: 9791425
[TBL] [Abstract][Full Text] [Related]
17. Mianserin.
Edwards IR
N Z Med J; 1985 May; 98(778):350. PubMed ID: 3858725
[No Abstract] [Full Text] [Related]
18. [Pneumopathies caused by metapramine].
Dombret MC; Saraux JL; Fagon JY; Smiejan JM; Thibault P
Presse Med; 1988 Mar; 17(8):389. PubMed ID: 2966373
[No Abstract] [Full Text] [Related]
19. Mianserin-induced agranulocytosis.
Br Med J (Clin Res Ed); 1982 Aug; 285(6339):437-8. PubMed ID: 6809113
[No Abstract] [Full Text] [Related]
20. Mianserin, agranulocytosis, and suicide.
Thomas CS; Read DA
Lancet; 1990 Dec; 336(8729):1511. PubMed ID: 1979118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
